Foresee Pharmaceuticals Co., Ltd. (TPEX:6576)

Taiwan · Delayed Price · Currency is TWD

77.70

-0.40 (-0.51%)

Mar 26, 2026, 1:30 PM CST

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
New Medicine Development	431.27M	418.69M	195.04M	301.51M	226.03M
New Medicine Development Growth	3.01%	114.67%	-35.31%	33.39%	-1.91%
Total	431.27M	418.69M	195.04M	301.51M	226.03M
Total Growth	3.01%	114.67%	-35.31%	33.39%	-1.91%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
United States	409.87M	193.95M	201.34M	-
United States Growth	111.33%	-3.67%	-	-
China	6.23M	1.01M	60.58M	-
China Growth	517.86%	-98.34%	-	-
Europe	2.59M	84.00K	39.59M	-
Europe Growth	2984.52%	-99.79%	-	-
Taiwan	-	-	-	226.03M
Taiwan Growth	-	-	-	-1.91%
Total	418.69M	195.04M	301.51M	226.03M
Total Growth	114.67%	-35.31%	33.39%	-1.91%

Source: S&P Global Market Intelligence.